willdate

366 POSTS 0 COMMENTS

AliveCor and Acutus partner for post-market study

AliveCor and Acutus Medical will collaborate to assess the integration of data collection tools across the cardiology continuum of care, which the companies say...

AngelMed launches its Guardian device in the USA

Angel Medical Systems (AngelMed) has announced the first commercial implantation and US launch of its The Guardian device. The procedure marks the Guardian's first...

Affera’s SpherePVI gets first-in-human use

Affera has announced the first-in-human use of its circumferential pulmonary vein isolation (PVI) pulsed field ablation (PFA) catheter, SpherePVI. The work was conducted as part...

MicroPort enters into Series C financing agreements

MicroPort Cardiac Rhythm Management (CRM) has entered into definitive agreements in connection with its Series C financing with total investment proceeds of US$150 million. Hillhouse...

Tyrx Envelope is effective at reducing infections in CIED patients with...

Medtronic has announced new data from the WRAP-IT study published in Heart Rhythm, which it said demonstrate a significantly lower infection risk for patients...

Cardiac rehabilitation reduces rehospitalisation, death in ICD recipients

People who made even small increases in their daily physical activity levels after receiving an implantable cardioverter defibrillator (ICD) experienced fewer incidences of hospitalisation...

“No evidence” to link moderate coffee consumption with arrhythmia risk

There is no evidence that moderate coffee consumption can cause cardiac arrhythmia, according to the authors of a prospective, population-based community cohort study, findings...

TVT 2021: Two-year PINNACLE FLX results report low rate of ischaemic...

Two-year results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation Watchman FLX (Boston Scientific) left atrial appendage closure...

Ancora Heart secures US$80 million in financing

Ancora Heart has closed US$80 million in equity financing, with the funds to be used to accelerate the CORCINCH-HF pivotal clinical study of the...

Research highlights AF risk factors for HCM patients

The authors of research published in JACC: Clinical Electrophysiology claim that their findings will help physicians to identify, treat and prevent atrial fibrillation (AF)...

First patients treated with reSept ASD occluder in IDE trial

atHeart Medical has announced the successful treatment of the first five patients in its ASCENT ASD US Investigational Device Exemption (IDE) pivotal trial. This...

AliveCor gains US FDA clearance for KardiaMobile 6L to calculate patients’...

AliveCor has today announced the receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for healthcare professionals to use the KardiaMobile...

FDA approval for SafeCross transseptal RF system

East End Medical has announced it has received US Food and Drug Administration (FDA) clearance for the company's SafeCross transseptal radiofrequency (RF) puncture &...

CABANA trial shows favourable results for catheter ablation among ethnic minority...

Among racial or ethnic minority patients enrolled in the North American cohort of the CABANA (Catheter ablation versus antiarrhythmic drug therapy for atrial fibrillation)...

Adagio’s ultra-low temperature cryoablation system in first-in-human use

Adagio Medical has announced successful first-in-human use of ultra-low temperature cryoablation (ULTC) for the treatment of monomorphic ventricular tachycardia (VT). The two-hour mapping and ablation...

First patient treated with VeriSight Pro 3D intracardiac echocardiography catheter

Royal Philips has announced the first procedure using its real-time 3D intracardiac echocardiography (ICE) catheter. The left atrial appendage occlusion (LAAO) procedure was carried...

Vaccine myocarditis risk “far outweighed” by COVID-19 infection

The risk of heart damage from COVID-19 infection is far greater than that from receiving a dose of the messenger RNA (mRNA) vaccine, according...

Boston acquires remaining shares of Farapulse

Boston Scientific has exercised its option to acquire the remaining shares of Farapulse. The acquisition will complement the existing Boston Scientific electrophysiology portfolio to...

Medtronic launches app-based study to probe relationship between AF disease burden...

Medtronic has announced the initiation of DEFINE AFib, an app-based research study which aims to address unanswered questions around atrial fibrillation (AF) burden and...

AngelMed gains FDA approval for enhanced real-time cardiac monitor for ACS...

Angel Medical Systems (AngelMed) has announced US Food and Drug Administration (FDA) approval of the second-generation AngelMed Guardian device. The AngelMed Guardian system is...

AHA statement on AF and HFrEF positive for catheter ablation

The American Heart Association (AHA) has this week issued a scientific statement on the management of atrial fibrillation (AF) in patients with heart failure...

CardioFocus receives Japanese approval for HeartLight X3

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the company's HeartLight X3 System for marketing in Japan....

Expanded FDA approval for Medtronic’s Arctic Front cryoablation catheter

Medtronic's Arctic Front Advance cryoballoon
Medtronic has received US Food and Drug Administration (FDA) expanded approval for the Arctic Front family of cardiac cryoablation catheters for the treatment of...

Heart Rhythm Society names new chief strategy officer

The Heart Rhythm Society (HRS) has announced the appointment of Simintha Esson as its new chief strategy officer (CSO). In this role, Esson is responsible...

ESC president urges vigilance over signs of cardiac arrest following Christian...

The president of the European Society of Cardiology (ESC) has called for greater awareness of the signs of cardiac arrest and how to respond,...

Remote heart failure monitoring platform offered to Imperial College patients

Imperial College Healthcare NHS Trust (London, UK) is working with remote healthcare developer, Luscii, to provide an at-home monitoring platform to support patients with...

Bluetooth-equipped pacemakers receive CE mark approval

MicroPort CRM has announced the European launch of Alizea and Borea pacemakers after receiving the CE mark under the new Medical Device Regulation. The...

Tech advancements in remote monitoring are connecting patients to better care

Robert Kowal is the chief medical officer of the Cardiac Rhythm businesses at Medtronic. In this interview he shares his views and experiences on...

Vaccination centre screening campaign reports success at “opportunistic” AF detection

A campaign by Arrhythmia Alliance to DETECT atrial fibrillation (AF)—the most common type of arrhythmia—found that 6% of people aged 65 or older attending...

RAFT-AF fails to show benefit of AF ablation in heart failure...

Among patients with both heart failure and atrial fibrillation (AF), treatment strategies focused on rhythm control, using catheter ablation, and those focused on rate...

Pulmonary artery proportional pulse pressure monitoring could improve survival for heart...

A new physiological measurement of heart function could improve survival for people with heart failure by identifying high-risk patients who require tailored treatments, a...

GE Healthcare and ACC partner to advance AI in cardiology

GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and participation in the ACC’s Applied Health Innovation Consortium for...

Medtronic announces publication of STROKE AF trial results

Medtronic has announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal LINQ insertable cardiac monitor (ICM) to detect...

Abbott’s Amplatzer steerable delivery sheath gains EU and Canadian approvals

Amplatzer Amulet
Abbott has announced it has received CE mark and Health Canada approval for its Amplatzer steerable delivery sheath, which is used with the company's...

Medtronic stops sale of its HVAD system

global registry of HVAD thoracotomy implants announced by Medtronic
Medtronic is stopping the distribution and sale of the Medtronic HVAD system. This morning, the company notified physicians to cease new implants of the...

Siemens Healthineers receives CE mark for the ACUSON AcuNav Volume ICE...

Siemens Healthineers has announced that it has received CE Mark for the AcuNav Volume ICE (intracardiac echocardiography) catheter, an imaging guide that provides real-time,...

Abiomed acquires breakthrough device company preCARDIA

Abiomed has acquired preCARDIA, developer of a proprietary catheter and controller to expand options for patients with acute decompensated heart failure (ADHF). The preCARDIA...

Implicity and MicroPort CRM partner for US distribution agreement

Implicity has announced a distribution agreement with MicroPort CRM, through which MicroPort CRM can sell and distribute Implicity's cloud-based solution in the USA as...

Wearables study shows physical activity reduces AF risk

Physical activity that conforms to medical and health association guidelines is associated with a lower risk of atrial fibrillation (AF) and stroke, according to...

MDR comes into effect across EU

The European Union (EU) Medical Devices Regulation (MDR) takes effect from today (26 May 2021). The Regulation revises quality and safety standards and the range...

iRhythm gains two FDA approvals for updates to its Zio system

iRhythm Technologies has announced two US Food and Drug Administration (FDA) 510K clearances—one for a new and improved design of its flagship monitor and...

Cardiomatics partners for tool to analyse ECG signals from paediatric patients

Cardiomatics and the Medical University of Warsaw, Warsaw, Poland are developing a tool for automatic assessment, analysis, and interpretation of electrocardiographic signals (ECG) from...

FDA issues public warning over interference from consumer electricals on implanted...

The US Food and Drug Administration (FDA) has issued advice to patients with implanted devices such as pacemakers or implantable defibrillators to take precautions...

ACC.21: Pandemic has seen burnout “double” among cardiology professionals

The proportion of cardiologists reporting burnout has nearly doubled during the COVID-19 pandemic, according to research presented at the American College of Cardiology’s 70th...

ACC.21: Registry data show low rate of stroke at one year...

Transcatheter left atrial appendage occlusion (LAAO) with a Watchman (Boston Scientific) device was associated with a low rate of stroke at one year, even...

ACC.21: LAAO after heart surgery offers “new paradigm” for stroke prevention...

Patients with an elevated risk of stroke due to arrhythmia or atrial fibrillation (AF), were much less likely to suffer a stroke after undergoing...

AI allows early diagnosis of low ejection fraction in primary care

An electrocardiogram (EKG)-based artificial intelligence (AI) algorithm based can enable the early diagnosis of low ejection fraction in patients in routine primary care, according...

Single-shot pulsed-field ablation yields “excellent” PVI durability

Pulmonary vein isolation (PVI) with a “single-shot” pulsed-field ablation (PFA) catheter results in excellent PVI durability and acceptable safety with a low one-year rate...

Acutus Medical announces CE mark approval for suite of EP products

Acutus Medical has announced CE mark approval for a broad suite of electrophysiology (EP) products including the AcQCross family of universal transseptal crossing devices,...

Hostile environment: Cardiologists report high prevalence of discrimination and harassment in...

Discrimination and harassment are a common experience among those working in cardiology, according to the findings from a global survey carried out by the...

Galaxy Medical and Japan Lifeline enter distribution agreement for pulsed electric...

Galaxy Medical (Galaxy) and Japan Lifeline (JLL) have announced an exclusive distribution agreement for the ALPHA1 ablation catheter in the USA, developed by Japan...

Cardiology trainees require training to adapt to shift towards telemedicine

A significant proportion of cardiology trainees are uncomfortable with using telemedicine and feel that better preparation for new-tech medicine is needed, findings of a...

Abbott initiates trial focusing on twin AF and heart failure treatments

Abbott has announced a new trial focused on improving the treatment for people simultaneously battling both atrial fibrillation (AF) and heart failure. The TAP-CHF trial...

AtriCure’s EPi-Sense system approved by US FDA for treatment of long-standing...

AtriCure has announced US Food and Drug Administration (FDA) approval of the EPi-Sense system to treat patients diagnosed with long-standing persistent atrial fibrillation (AF). The...

Hospitalised COVID-19 patients at risk of developing heart failure

Patients hospitalised with COVID-19 may be at risk of developing heart failure even if they do not have a previous history of heart disease...

EHRA 2021: Study advocates screening ICD patients for depression and anxiety

Patients receiving an implantable cardioverter defibrillator (ICD) should be regularly screened for anxiety and depression, according to research presented at the European Heart Rhythm...

Smartphone ECG screening app aided detection of AF among American Indians

A smartphone-based electrocardiogram (ECG) screening accurately detected previously unknown atrial fibrillation (AF) in American Indians, and more than half who were diagnosed were younger...

EHRA 2021: Diabetic patients could be screened for AF during foot...

Atrial fibrillation (AF) could be detected during annual foot assessments in patients with diabetes, according to research presented today at the European Heart Rhythm...

Putting the patient at the centre of the AF treatment strategy

This article was sponsored by Biosense Webster Putting the patient at the centre of the discussion is vital to setting the right strategy for the...

Oxford study to assess smart devices for AF detection

A project at Oxford University Hospitals NHS Foundation Trust (Oxford, UK) to test how effective smart devices are at detecting heart rhythm problems has...

AcQCross transseptal crossing devices gain US FDA clearance

Acutus Medical has announced US Food and Drug Administration (FDA) clearance of the AcQCross family of universal transseptal crossing devices. The transseptal puncture system...

MultiPulse therapy “shows promise” in the treatment of AF

Cardialen has announced the publication of a first-in-human study in the Journal of the American College of Cardiology: Clinical Electrophysiology investigating its low-voltage MultiPulse...

Report aims to improve diagnosis and treatment of SVT

The charity Arrhythmia Alliance has launched the Arrhythmia Alliance Healthcare Pioneers Report—Showcasing Best Practice in SVT to provide examples of good care to improve...

COVID-19 “lays the foundation for a digital shift in cardiovascular care”

More patients, particularly those with medical risk factors or from underserved communities, opted into telehealth appointments for their cardiovascular care during the COVID-19 pandemic,...

Charity targets vaccine centres for opportunistic AF screening campaign

AF Association has launched an opportunistic screening programme to DETECT atrial fibrillation (AF) at COVID-19 vaccination clinics across the UK. The charity has created...

ACC launches NCDR EP device implant registry

The American College of Cardiology (ACC) has launched the EP Device Implant Registry, which will include data on ICD and CRT-D procedures previously captured...

US enrolment in AcQForce Flutter IDE clinical trial commences

Acutus Medical has announced initial US enrolment in the company’s AcQForce Flutter Investigational Device Exemption (IDE) clinical trial. The trial is expected to enrol...

Dipti Itchhaporia begins term as ACC president

Dipti Itchhaporia has today begun her term as president of the American College of Cardiology (ACC). During her one-year presidency, she will lead the...

DOACs show better safety and effectiveness versus warfarin in patients with...

Patients with valvular atrial fibrillation (AF) who were new users of direct oral anticoagulants (DOACs) were at lower risk for ischaemic stroke or systemic...

One in three female cardiologists report unwanted advances

More than a third of female cardiologists polled in a UK survey on discrimination and sexism in the profession have reported receiving unwanted sexual...

US FDA grants Breakthrough Device Designation for AF ECG analysis platform

Tempus has announced that the US Food & Drug Administration (FDA) has granted the company Breakthrough Device Designation for its ECG analysis platform. The...

Daiichi Sankyo leads partnership to improve access to at-home AF diagnostics

Daiichi Sankyo has announced that it has entered into a collaborative agreement with three technology partners—FibriCheck, neoHealthTech and Capitol Medicare—to improve timely detection and...

Mavacamten granted US FDA new drug application

Bristol Myers Squibb has announced that the US Food and Drug Administration (FDA) has accepted its new drug application (NDA) for mavacamten, an investigational,...

Higher procedural volume linked to better outcomes for LAAO

Higher procedural volume is associated with better outcomes for percutaneous left atrial appendage occlusion (LAAO) procedures, research published online in JACC: Cardiovascular Interventions has...

Index-beat approach improves diagnosis of heart failure in AF patients

An assessment method known as the index-beat approach could improve the diagnosis of heart failure in patients with atrial fibrillation (AF), authors of a...

Medtronic receives CE mark for catheter system and cardiac pacing lead...

Medtronic
Medtronic has announced CE mark approval for the SelectSite C304-HIS deflectable catheter system, as well as CE mark labelling expansion for the SelectSecure MRI...

Looking ahead to AFIB2021

Far from being the first event in the electrophysiology calendar now to make the switch to a digital-only format, the 2021 edition of the...

Qardio receives US FDA clearance for QardioCore continuous ambulatory ECG

Qardio has announced that the US Food and Drug Administration (FDA) has granted the company 510(k) clearance for its QardioCore ambulatory ECG device. QardioCore...

Five-year results of Gore REDUCE clinical study published

Five-year follow-up results from the Gore REDUCE study, assessing the Gore Cardioform or Helex septal occluder versus antiplatelet therapy in long-term recurrent stroke prevention,...

ACC.21 late-breaking clinical trial programme announced

The American College of Cardiology (ACC) has announced a number of the late-breaking clinical trials to be presented at its 70th annual scientific session...

CorSystem announces first use of Bipolar Ablation Adapter

CorSystem has announced the first use of its Bipolar Ablation Adapter since the device received CE mark in July 2020. The patient who underwent treatment...

Inflammatory heart disease “rare” among athletes with COVID-19

Inflammatory heart disease is a rare finding among professional athletes with mild or asymptomatic COVID-19 infection, a large-scale study has found. The study, led...

ControlRad Select imaging system gains FDA market clearance

ControlRad has announced US Food and Drug Administration (FDA) 510(k) clearance to market ControlRad Select, a technology that utilises proprietary semi-transparent filters, a user-interface...

First procedures performed in pivotal trial to evaluate PulseSelect PFA system

Medtronic has announced the first procedures in the investigational device exemption (IDE) pivotal trial to evaluate the PulseSelect pulsed field ablation (PFA) system, a...

AF burden at six months predictive of hard clinical outcomes in...

Atrial fibrillation (AF) burden at six months after catheter ablation is predictive of all-cause mortality and heart failure hospitalisation,  in AF patients with heart...

Societies collaborate to develop universal heart failure definition

A global collaboration between international heart failure bodies seeks to standardise the language and practices around the definition and classification of heart failure around...

Open-source platform could aid study of AF

An open-source platform, OpenEP, has been made available to advance research on atrial fibrillation (AF), which developers claim can perform 90% of the analyses...

First patients treated in ADVENT trial of pulsed field ablation system

FARAPULSE has announced that the first patients have been treated in the ADVENT trial, a US Food and Drug Administration (FDA) Investigational Device Exemption...

SCREEN-AF study results published in JAMA Cardiology

iRhythm Technologies collaboration
iRhythm Technologies has announced the results of the SCREEN-AF study, led by researchers at Sunnybrook Health Sciences Centre in Toronto, Canada and University Hospital...

Analysis of REVERSE trial points to CRT benefit for heart failure...

Medtronic has announced new results from the REVERSE trial, evaluating outcomes of cardiac resynchronisation therapy (CRT) for patients with mild heart failure (HF). The...

HeartLight X3 pivotal study meets safety and efficacy endpoints

CardioFocus has announced that results from the HeartLight X3 Pivotal Study have been published online in the journal Circulation: Arrhythmia and Electrophysiology (CircEP), showing...

Piccolo Medical receives US FDA clearance for SmartPICC system

Piccolo Medical has announced that it has received US Food and Drug Administration (FDA) clearance of its SmartPICC system. The SmartPICC system offers the ability...

ACC.21 switches to a virtual-only meeting

The American College of Cardiology (ACC) has announced that its 70th annual scientific session, will be held as an all virtual meeting. The meeting...

Urgent action needed to address growing burden of heart failure

Urgent action is needed to address the growing burden of heart failure and the impact of COVID-19 in the UK, according to a report...

RhythMedix releases its next-generation wearable cardiac telemetry monitor

RhythMedix has announced the release of its next-generation RhythmStar wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is worn for...

MicroPort Academy CRM launched to aid training in cardiac pacing therapy

MicroPort CRM has launched an online education website—MicroPort Academy CRM—dedicated to cardiac pacing therapy and the functionality of MicroPort CRM products. MicroPort Academy CRM provides...

Global heart failure cases soar since 1990

The number of patients with heart failure worldwide nearly doubled from 33.5 million in 1990 to 64.3 million in 2017 according to research published...

New recommendations issued on antithrombotic treatment of AF patients undergoing PCI

Updated recommendations on the optimal antithrombotic treatment of patients with atrial fibrillation (AF) receiving oral anticoagulants after undergoing percutaneous coronary intervention (PCI) have been...

MedLumics closes on financing round and makes board appointment

MedLumics has announced that it has closed an €18 million (US$21.7 million) financing round and has appointed Rich Ferrari as Chairman of the Board...

CardiacSense’s AF monitoring watch gains CE mark

CardiacSense has received the CE mark to market and sell a medical grade watch which can detect and remotely monitor atrial fibrillation (AF) and...

Philips completes acquisition of cardiac diagnostics specialist BioTelemetry

Royal Philips has announced that it has completed the acquisition of BioTelemetry, a US provider of remote cardiac diagnostics and monitoring. The acquisition of BioTelemetry...

“Strong evidence” of a causal link between high blood pressure and...

A study published in the European Journal of Preventive Cardiology provides “strong evidence” of a causal relationship between elevated blood pressure and atrial fibrillation...

B-Secur receives FDA clearance for its HeartKey EKG/ECG technology

B-Secur has announced that it has received US Food and Drug Administration (FDA) 510(K) clearance for its HeartKey software library. B-Secur’s HeartKey is a suite...

AF Symposium 2021: Experts debate early ablation strategy in AF

The merits of catheter ablation as a first-line treatment for atrial fibrillation (AF) were considered during the second day of AF Symposium 2021 (29–31...

AF Symposium 2021: HARTCAP-AF supports hybrid over catheter ablation

Hybrid ablation, a procedure which involves “attacking” the atrial substrate from the epicardium and endocardium, has been shown to result in significantly higher freedom...

AF Symposium 2021: Studies explore lattice-tip catheter strategies for AF

Findings of two studies investigating the use of a lattice-tip catheter for the treatment of atrial fibrillation (AF) were presented during a late-breaking trial...

AI-enabled mobile device rapidly and accurately determines QTc

Researchers using artificial intelligence (AI) have determined that a smartphone-enabled mobile EKG device can accurately determine a patient’s QT. This can be used to...

AF Symposium 2021: Hybrid, multidisciplinary therapy superior to catheter ablation for...

Results of a sub-analysis of the CONVERGE clinical trial, presented during a late-breaking trial session at the digital AF Symposium (29–31 January, virtual), suggest...

Medtronic receives FDA approval for DiamondTemp ablation system

Medtronic has received US Food and Drug Administration (FDA) approval for the DiamondTemp ablation (DTA) system which treats patients with recurrent, symptomatic paroxysmal atrial...

AF Symposium 2021: Live case from ECLIPSE-AF study to feature

Galaxy Medical, a developer of pulsed electric field (PEF) technology for the treatment of cardiac arrhythmias, has announced that the proprietary Centauri system will...

AF Symposium 2021: Early results of CathVision Cube to be announced

CathVision ApS has announced that its novel cardiac electrophysiology system and artificial intelligence platform to guide ablation therapy for heart rhythm disorders, will be...

AF Symposium 2021: Two cases highlight Acutus’ mapping technology

Acutus Medical has announced a number presentations relating to its mapping and ablation procedures during 26th Annual International AF Symposium (29–31 January, virtual). The...

Farapulse gains CE mark for its pulsed field ablation system

Farapulse announced that it has received the CE mark for its pulsed field ablation (PFA) system for the treatment of paroxysmal atrial fibrillation (AF)....

RHYTHM AI announces latest publication of data backing its STAR Mapping...

RHYTHM AI has announced publication of a clinical outcome study for its STAR (Stochastic Trajectory Analysis of Ranked signals) Mapping system, which is designed...

Cardialen awarded US$2.8 million grant for study of low-energy cardioversion in...

Cardialen has been awarded a US$2.8 million National Institutes of Health (NIH) phase II SBIR grant to further the clinical study of low-energy cardioversion...

Kardium secures financing to advance Globe mapping and ablation system

Kardium has raised US$115 million in a new financing round, which will be used to accelerate commercial growth of the Globe mapping and ablation...

Blood pressure bracelet “offers greater insight” into hypertension

Following the announcement of CE mark approval for the Aktiia cuffless blood pressure monitor bracelet, Gregoire Wuerzner (Lausanne University Hospital and University of Lausanne,...

Richer European countries have higher AF death rates than their less...

The wealthiest countries in Europe have higher death rates from atrial fibrillation (AF) than the least wealthy and these death rates are increasing more...

Aktiia’s wrist-mounted blood pressure monitor gains CE mark

Aktiia has announced that its automated blood pressure monitoring system has received the CE mark as a Class IIa medical device. With the CE...

InCarda Therapeutics announces enrolment of first US patient in phase 2...

InCarda Therapeutics has announced dosing of the first US patient in the company’s multinational INSTANT Phase 2 clinical trial of InRhythm (flecainide for inhalation)...

Boston Scientific to acquire Preventice Solutions

Boston Scientific has entered into a definitive agreement to acquire Preventice Solutions, a privately-held company which offers a full portfolio of mobile cardiac health...

Remote technology in cardiac care is “here to stay”

Robert Klempfner, is director of the Israeli Center for Cardiovascular Research, and director of the Cardiovascular Prevention and the Cardiac Rehabilitation Institutes at Sheba...

Activating patient engagement to evolve AF care

Patient engagement is key to optimising outcomes in the treatment of atrial fibrillation (AF) argues Elana Arbelo (Consultant Cardiac Electrophysiologist and Community Cardiologist, Hospital...

Wearables offer “great potential” in AF screening but physicians cautious over...

Consumer wearables offer a great potential for the screening of atrial fibrillation (AF), however two thirds of healthcare professionals admit to concerns over mass...

Wearable devices: The new frontier in arrhythmia management?

“I believe, if you zoom out into the future, and you look back, and you ask the question, ‘What was Apple’s greatest contribution to...

Regular alcohol consumption linked to increased AF risk

A study of nearly 108,000 people has found that people who regularly drink a modest amount of alcohol are at increased risk of atrial...

Volta Medical secures €23 million in financing round

Volta Medical, a French health technology startup working on artificial intelligence (AI) algorithms to treat cardiac arrythmias, has announced that it has successfully raised...

ACC.21 to offer remote COVID-19 screening

The American College of Cardiology (ACC) is partnering with BioIntelliSense, a continuous health monitoring and clinical intelligence company, to advance remote patient monitoring (RPM)...

Warning over smartphone interference inhibiting ICD therapy

A letter published in the journal Heart Rhythm has warned of possible interference to implantable cardioverter defibrillator (ICD) therapy caused by magnets in the...

Jian’an Wang named as editor of JACC: Asia

Jian’an Wang (Heart Center, Zhejiang University, Hangzhou, China) has been named the inaugural editor-of-chief of JACC: Asia, a new journal from the American College...

High power CLOSE-guided PVI “increases procedural efficiency”

Results of a prospective randomised evaluation of using high power during CLOSE-guided pulmonary vein isolation (PVI) using the Thermocool Smarttouch (Biosense Webster) device—the POWER-AF...

Canadian approval for Medtronic’s Micra AV pacemaker

Medtronic Canada has received a Health Canada licence for Micra  AV, the world's smallest pacemaker with atrioventricular (AV) synchrony. Micra AV is indicated for...

PRECAF study looks at elimination of distal coronary sinus to left...

Elimination of distal coronary sinus (CS) to left atrial (LA) connections reduced atrial arrhythmia recurrences compared to standard pulmonary vein (PV) isolation and non-PV...

ACC recommends against “triple therapy” in AF patients

The American College of Cardiology (ACC) has issued guidance recommending against triple antithrombotic therapy in patients with atrial fibrillation (AF), due to its increased...

Philips to acquire cardiac monitoring specialist BioTelemetry

Royal Philips has agreed a merger agreement with BioTelemetry, a cardiac monitoring company focused on the diagnosis and monitoring of heart rhythm disorders. Philips will...

Abbott’s HeartMate 3 LVAD receives approval for paediatric use

Abbott has announced that the US Food and Drug Administration (FDA) has approved updated labelling for the company's HeartMate 3 heart pump to be...

US FDA clears vital data sensor in Biomonitor IIIm

Biotronik has today announced US Food and Drug Administration (FDA) clearance and availability of the Vital Data Sensor, which identifies body temperature increases potentially...

CardioFocus announces 10,000-patient milestone for HeartLight ablation system

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has announced that more than 10,000 patients worldwide have been treated with the HeartLight endoscopic ablation system. The HeartLight system is a catheter ablation...

Patient enrolment begins in Astral-4LV clinical trial

MicroPort Cardio Rhythm Management (CRM) has announced the first enrolment in the Astral-4LV clinical trial to evaluate the safety and efficiency of Axone, a...

European launch for Acutus Medical’s AcQCross transseptal crossing system

Acutus Medical has announced CE mark approval and the European launch of its integrated family of transseptal crossing products, designed to deliver safe and...

Volta Medical’s VX1 AI software for use in AF mapping now...

Volta Medical has announced that it has obtained US Food and Drug Administration (FDA) clearance for its VX1 AI (artificial intelligence) software. According to...

Biotronik receives CE mark for AICath Force ablation catheter

Biotronik has announced CE mark approval for the AlCath Force the gold-tipped force sensing ablation catheter system. The AlCath Force was designed specifically to show...

Heavy alcohol consumption leads to higher stroke risk in AF patients

Fourteen drinks a week is linked with a higher risk of stroke and embolism in patients with atrial fibrillation (AF), according to research published...

Study compares WatchPAT to in-lab diagnosis of sleep apnoea in AF...

Itamar Medical has announced the publication of a study in the December 2020 edition of Nature and Science of Sleep validating the use of...

Acutus Medical launches the AcQBlate force sensing ablation system in Europe

Acutus Medical has announced the launch of the AcQBlate force sensing ablation system in Europe after securing CE mark for the company’s AcQBlate FORCE...

Cathy Gates named as ACC’s new CEO

Cathy Gates has been named as the new CEO of the American College of Cardiology (ACC), effective immediately. Gates has been serving as interim...

Anticoagulants fail to improve survival from COVID-19, Swedish study finds

The use of direct oral anticoagulants (DOACs) did not reduce the rate of hospitalisation, intensive care admission or fatality due to COVID-19, according to...

Zio XT cardiac monitor recommended for NICE guideline adoption

iRhythm Technologies collaboration
iRhythm Technologies has announced it is the first technology to pass through a new digital health tech pilot, resulting in a successful recommendation for...

Rhythm AI announces publication of STAR mapping study

Rhythm AI has announced publication of a human clinical outcome study for its Stochastic Trajectory Analysis of Ranked signals (STAR) mapping system in Circulation:...

AHA 2020: Active AF screening associated with significant improvement in clinical...

Three-year clinical outcomes of the mHealth Screening to Prevent Strokes—mSToPS—study evaluating silent, or previously undiagnosed, atrial fibrillation (AF) in moderate-risk individuals using Zio, the...

AHA 2020: AF detected more often in high risk patients recovering...

Atrial fibrillation (AF) was detected up to 10 times more frequently in high risk patients recovering from heart surgery who wore a continuous cardiac...

AHA 2020: Medtronic shares results of cryoablation studies

Medtronic's Arctic Front Advance cryoballoon
Medtronic has announced the presentation of results of three studies which it says demonstrate that cryoablation is superior to drug therapy for first-line treatment...

AHA 2020: InCarda announces presentation of INSTANT trial data

InCarda Therapeutics has announced the presentation of positive data from the open-label, dose-escalation Part A portion of the company’s multinational INSTANT Phase 2 clinical...

AHA 2020: Rivaroxaban may be comparable to warfarin for bioprosthetic mitral...

The primary results from the RIVER Trial—Rivaroxaban for Valvular Heart disease and Atrial Fibrillation—show that rivaroxaban is comparable to warfarin for patients with bioprosthetic...

Adagio closes US$42.5 million Series E financing

Adagio, developer of the intelligent Continuous Lesion Ablation System (iCLAS), has announced that it has closed a US$42.5 million Series E equity financing. Proceeds...

Kardium announces first clinical use of Globe Positioning System

Kardium has announced the first clinical use of the Globe Positioning System—a 3D mapping and navigation feature of its flagship product, the Globe Mapping...

Append Medical completes transcatheter implant-free LAA occlusion procedures

Append Medical, developer of the Appligator implant-free left atrial appendage (LAA) occlusion device, today announced completion of its first pre-clinical chronic procedures. The procedures...

AliveCor appoints Toby Cosgrove to board of directors

AliveCor has announced the appointment of Toby Cosgrove to its board of directors. For more than 13 years, through to 2017, Cosgrove served as...

HeartHero receives CE mark for automated external defibrillator device

HeartHero has announced that its automated external defibrillator (AED) device—known as Elliot—has received CE mark approval. In a press release, the company said that...

American Heart Association issues call for action on structural racism in...

Structural racism is a major cause of poor health and premature death from heart disease and stroke, according to a presidential advisory issued today...

AHA 2020: Higher level of fitness reduces atrial fibrillation risk

Higher fitness levels reduced the risk of developing atrial fibrillation (AF) by 30‒50% in a study of male, African American veterans, according to preliminary...

Study draws link between physician payments and device selection

Payments from device manufacturers to physicians are likely to have a bearing on device selection in patients receiving an implantable cardioverter defibrillator (ICD) or...

Procedural success comparable in CRT implants and upgrades

Rates of procedural success and complications were no different between de novo cardiac resynchronisation therapy (CRT) implantations and upgrades, a study published in JACC:...

European and Australian approvals granted for Abbott’s cardiac mapping system EnSite

Abbott has announced has announced the receipt of CE mark and approval in Australia for its EnSite X EP System, and is launching the...

Machine learning approach could detect drivers of atrial fibrillation

Researchers have designed a new machine learning-based approach for detecting atrial fibrillation (AF) drivers, small patches of the heart muscle that are hypothesised to...

Boston Scientific initiates CHAMPION-AF trial of Watchman FLX

Boston Scientific has initiated the CHAMPION-AF clinical trial to evaluate the safety and efficacy of the Watchman FLX left atrial appendage closure (LAAC) device...

ESC events to continue digitally in 2021, society announces

The European Society of Cardiology (ESC) has announced that its full portfolio of congresses, teaching courses and exams in 2021—including the ESC Congress 2021—will...

InCarda raises US$30 million through Series C financing

InCarda Therapeutics, has raised US$30 million through the first close of a Series C equity financing. The financing was led by an affiliate of...

MRI scans can be performed safely in non-MR ICDs, study finds

Magnetic resonance imaging (MRI) examinations can be performed safely in patients with non-MR compatible cardiac devices, including those who are pacemaker-dependent or have abandoned...

Research programme to probe causes of unexplained cardiac arrest

A research programme into understanding the underlying causes of unexplained cardiac arrest has received significant backing from the British Heart Foundation (BHF). The four-year project,...

JACC journal series looks at impact of COVID-19 on cardiovascular health

The Journal of the American College of Cardiology (JACC) has issued a three-part focus seminar on COVID-19 in 2020 to address the complex relationship...

Conformal LAAC studies presented at TCT Connect 2020

Conformal Medical has announced positive clinical data from first-in-human studies performed in the USA and Czech Republic, following trials of its left atrial appendage...

High-risk surgery patients vulnerable to cardiovascular diseases

One in five high-risk patients undergoing major non-cardiac surgery will develop one or more heart complications within a year, according to research published today...

BMJ study proves efficacy of Coala Heart Monitor as part of...

Coala Life has announced the results of a late breaking trial on cryptogenic stroke patients. In the TEASE-study, recently published in the British Medical...

First patients treated with the Centauri pulsed electric field system

Cardiac Rhythm news for specialists
Galaxy Medical, a developer of pulsed electric field (PEF) technology, has announced that the first patients in the ECLIPSE-AF study were successfully treated with...

VivaLNK and AMPS partner on data-gathering from remote ECGs

VivaLNK and AMPS have partnered to advance remote patient monitoring (RPM) for clinical trials, combining AMPS’ continuous electrocardiogram (ECG) recording suite with VivaLNK medical...

Rhythm AI gets green light for ROCSTAR clinical trial

Rhythm AI has today announced that it has received approval from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to proceed with its...

Development of AF after CABG linked to higher risk of cerebrovascular...

Patients with postoperative atrial fibrillation (AF) after coronary artery bypass graft (CABG) surgery are at a higher risk of cerebrovascular accidents (CVAs) up to...

Catheter ablation linked to lower incidence of dementia in AF patients

People with atrial fibrillation (AF) have a reduced risk of dementia if they undergo catheter ablation to restore the normal rhythm of their heart,...

US FDA approves Biosense Webster’s Thermocool Smarttouch SF ablation catheter

Johnson & Johnson Medical Devices Companies has announced the US Food and Drug Administration (FDA) approval of Biosense Webster’s Thermocool Smarttouch SF ablation catheter...

First patient implanted with next-generation AngelMed Guardian system

AngelMed has announced the first implant of the next-generation AngelMed Guardian system as part of the ALERTS-Continued Access Study. The AngelMed Guardian is an...

Holographic ablation guidance system gains US FDA clearance

SentiAR has received US Food and Drug Administration (FDA) 510(k) clearance for its CommandEP system, the first holographic guidance system to be used during...

First patients in Europe treated with Biosense Webster Varipulse catheter

Johnson & Johnson has announced that Biosense Webster has enrolled and treated the first patients in its inspIRE clinical study in Europe. The study...

Shouvik Haldar announced as Heart Rhythm Congress programme director

Shouvik Haldar (London, UK) has been announced as the new A-A Heart Rhythm Congress programme director, following the decision by Kim Rajappan (Oxford, UK)...

Study finds over 2,000 excess cardiovascular deaths in England and Wales...

Research has identified 2,085 excess deaths in England and Wales linked to cardiovascular disease during the peak of the COVID-19 pandemic. On average, that...

Twin studies demonstrate the evolving S-ICD evidence-base

This advertorial has been sponsored by Boston Scientific Two landmark studies have been published in 2020 following the use of subcutaneous implantable cardioverter defibrillator (S-ICDs)...

Low rate of arrhythmia in COVID-19 patients undergoing short-term hydroxychloroquine treatment

Short-term hydroxychloroquine treatment is not associated with lethal heart rhythms in patients with COVID-19 who are risk assessed prior to receiving the drug. That...

First patients enrolled in study of LINQ ICM to detect heart...

Medtronic has announced the first enrolments in the ALLEVIATE-HF clinical trial which will evaluate the ability of its Reveal LINQ insertable cardiac monitor (ICM)...

VivaLNK wearable ECG to be used in AF biomarkers study

VivaLNK has announced that the University of California, San Francisco (UCSF) (San Francisco, USA), will be utilising its continuous wearable electrocardiogram (ECG) sensor for...

Breakthrough status for Medtronic’s Tyrx for use with ventricular assist devices

Medtronic has received Breakthrough Device Designation status from the US Food and Drug Administration (FDA) for the Tyrx absorbable antibacterial driveline wrap, which is...

Boston Scientific to invest in pulsed field ablation device developer

Boston Scientific has signed an investment agreement with an exclusive option to acquire Farapulse, a privately-held company developing a pulsed field ablation (PFA) system...

US FDA approval for second generation AcQMap system

Acutus Medical has announces US Food and Drug Administration (FDA) 510(k) clearance of the second-generation AcQMap 3D imaging and mapping catheter which builds on...

Redesigning pathways to incorporate innovative technologies into primary care

Yassir Javaid (Northampton, UK) discusses the use of cloud-based technologies and machine learning to improve the treatment and detection of arrhythmias. What potential is there...

Heart Rhythm Congress gears up for first digital-only event

Details of the digital format for the Arrhythmia Alliance’s Heart Rhythm Congress 2020 (27–30 September) have been released, with the event to be hosted...

Medtronic’s TYRX envelope found to be cost effective for patients at...

Medtronic has announced new data from the WRAP-IT study, showing the TYRX absorbable antibacterial envelope (TYRX Envelope) is cost effective for patients at increased...

CoreMap completes US$10.5 million financing round

CoreMap has announced the completion of a US$10.5 million Series A financing round led by Qure Ventures. The round included existing investors such as...

Air pollution exposure multiplies risk of stroke in AF patients

Sufferers of atrial fibrillation (AF) who are exposed to greater levels of pollution have a 1.2-fold higher risk of stroke than their peers who...

VitalConnect begins TELESTAR-TAVR remote monitoring study

VitalConnect has announced the commencement of the TELESTAR-TAVR clinical study—Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients)—monitoring patients undergoing...

AHA calls for awareness of medication-induced arrhythmias

Healthcare professionals should become more familiar with medications that cause arrhythmias, according to a new scientific statement from the American Heart Association (AHA), published...

Stereotaxis robotic navigation systems installed in Phoenix and Helsinki

Stereotaxis has completed installations of the world’s first Genesis Robotic Magnetic Navigation (RMN) systems to treat heart rhythm disorders at Helsinki University Hospital in...

Arrhythmia Alliance launches online event for heart rhythm patients

Arrhythmia Alliance and its sister charities will launch the first virtual Patients Day on 27 September, with thousands of heart rhythm patients and healthcare...

Fitbit receives US and European approvals for ECG app to identify...

Fitbit has received 510(k) clearance from the US Food and Drug Administration (FDA), as well as Conformité Européenne (CE) marking in the European Union,...

Acutus announces pre-clinical results of a novel diagnostic workflow using its...

Acutus Medical has announced pre-clinical experimental results of a novel diagnostic and therapeutic workflow utilising the AcQMap system along with tissue-selective, non-thermal pulse field...

iRhythm wins AI award funding to trial Zio at NHS sites

iRhythm Technologies collaboration
iRhythm Technologies has been named a winner of the UK government’s Artificial Intelligence (AI) in Health and Care Award. The announcement was made by...

ACC announces revised dates for ACC.21

The American College of Cardiology (ACC) has announced that its 70th Annual Scientific Session, ACC.21 taking place in Atlanta, USA, will be held across...

Philips launches latest version of its Azurion imaging platform

Royal Philips has announced the next-generation of its Azurion image-guided therapy platform, designed to improve the quality and efficiency of interventional procedures. The Azurion...

ESC 2020 Congress: IMPACT-AFib finds no statistical difference in anticoagulant usage

A study investigating an educational intervention aimed at increasing the use of oral anticoagulants for stroke prevention among atrial fibrillation (AF) patients, found that...

Cardiologs and MicroPort CRM partner to offer AI-based ECG system in...

Cardiologs has announced an exclusive distribution agreement in France with MicroPort CRM, for the reselling of its cloud analysis solution for Holter electrocardiograms (ECGs)....

ESC 2020 Congress: Digoxin found to be favourable in rate control...

Digoxin should be considered as a first-line approach for rate control in patients with permanent atrial fibrillation (AF). This was the conclusion of the...

ESC 2020 Congress: AF associated with long-term mortality in primary PCI...

Atrial fibrillation (AF) is associated with long-term mortality in patients undergoing primary percutaneous coronary intervention (PCI), irrespective of left ventricular (LV) function, a study...

ESC 2020 Congress: Daiichi Sankyo announces results from ETNA-AF studies

Cardiac Rhythm news for specialists
Daiichi Sankyo Europe has announced one-year results of four sub-analyses from the European and global ETNA-AF (Edoxaban Treatment in routiNe clinical prActice in patients...

ESC Congress 2020: EAST-AFNET 4 finds early rhythm control improves AF...

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy, according to results of the EAST-AFNET 4 trial presented in a Hot...

ESC 2020 Congress: STOP AF First finds cryoballoon ablation safer than...

Cryoballoon catheter ablation as a first line treatment for paroxysmal atrial fibrillation (AF) was found to be safer and more effective than anti arrhythmic...

ESC Congress 2020: Guidelines push individualised approach to AF

Patients with arrhythmia should choose the treatment plan with their health professionals, according to European Society of Cardiology (ESC) guidelines published online today in...

Heart Rhythm Society publishes Cardiovascular Digital Health Journal

The Heart Rhythm Society has announced the publication of the inaugural issue of the Cardiovascular Digital Health Journal. The new journal focuses on the...

Biosense Webster launches latest generation of Carto heart mapping system

Johnson & Johnson Medical Devices Companies has today announced the launch of Biosense Webster’s Carto 3 system version 7 and the Carto Prime mapping...

Philips announces new imaging enhancements for Kodex-EPD system

Royal Philips has announced new imaging and workflow enhancements for its Kodex-EPD cardiac imaging and mapping system. The system is used to treat patients...

ESC Congress 2020: Smoking cessation linked to reduced stroke risk in...

Research presented at the ESC Congress 2020 (Virtual, 29 August–1 September) suggests that, among atrial fibrillation (AF) patients, those who quit smoking were 30%...

Low rates of bleeding and mortality reported in one-year results of...

Daiichi Sankyo Europe has announced the publication of one-year follow-up results from the ongoing ETNA-AF-Europe (Edoxaban Treatment in routiNe clinical prActice for patients with...

Digital platform takes 2020 ESC Congress to a wider audience

Ahead of the 2020 European Society of Cardiology (ESC) Congress, taking place from 29 August–1 September, the event’s scientific chair Marco Roffi (University Hospitals...

Using advanced imaging to tackle complex arrhythmias

J Peter Weiss (Heart Institute, Banner University of Arizona Medical Center, Phoenix, USA) outlines his experience of the AcQMap (Acutus Medical) 3D imaging and...

Biosense Webster receives CE mark approval for QDot Micro ablation catheter

Johnson & Johnson Medical Devices has today announced European CE mark approval of Biosense Webster’s QDot Micro radiofrequency (RF) ablation catheter. According to a press...

Atrial fibrillation deaths “declining”, study finds

A study by researchers from the Boston University School of Public Health (BUSPH, Boston, USA) shows a decline in deaths related to atrial fibrillation...

First procedures performed in the USA using Watchman FLX LAAC device

Physicians at the Texas Cardiac Arrhythmia Institute (TCAI) at St David's Medical Center in Austin and Los Robles Health System in Thousand Oaks, became...

Fitness linked to lower arrhythmia recurrence after AF ablation

Patients undergoing atrial fibrillation (AF) ablation, who are physically fit before the procedure, have a much higher chance of benefiting from the procedure and...

JAHA retracts paper calling for end to cardiology diversity programmes

The Journal of the American Heart Association (JAHA) has retracted a paper published in March 2020, which drew criticism due to its conclusions about race and the role of affirmative action within...

Conformal Medical secures funding to support CLAAS device trial

Conformal Medical, a medical device company focused on reducing stroke in patients with atrial fibrillation (AF), today announced it has secured US$85 million in...

Integrated cardiac ablation performed using remote telerobotic system

Stereotaxis and Acutus Medical have announced the first integrated cardiac ablation procedure using remote TeleRobotic support. Gery Tomassoni of Baptist Health, Lexington, USA treated...

Eko and AstraZeneca announce digital cardiovascular health partnership

Eko has announced a collaboration with AstraZeneca to accelerate the development of digital health tools for the earlier screening of cardiovascular diseases, including heart...

Abbott begins IDE study of TactiFlex device for paroxysmal AF

Abbott has announced first enrolments in the TactiFlex PAF IDE study to evaluate a new device to treat people suffering from paroxysmal atrial fibrillation...

Adagio Medical reports pre-clinical success combining cryoablation catheter with pulsed field...

Adagio Medical, developer of the intelligent Continuous Lesion Ablation System (iCLAS), has announced successful pre-clinical results demonstrating its existing cryoablation catheter is also capable...

Prompt diagnosis “vital” in effective AF management

Dhiraj Gupta, consultant cardiologist and electrophysiologist at Liverpool Heart and Chest Hospital, (Liverpool, UK) discusses the current burden of atrial fibrillation (AF) on healthcare...

Mobile phones and smartwatches pose little risk of CIED interference

The risk of electromagnetic interference to cardiovascular implantable electronic devices (CIEDs) from smartwatches and mobile phones is low—although close proximity between an iPhone 6...

American College of Cardiology to launch JACC: Asia

The American College of Cardiology (ACC) is expanding its JACC family of peer-reviewed journals to include JACC: Asia, which will publish original manuscripts focused...

Holographic display may improve physician accuracy during cardiac ablation

Details of the first-in-human use of an augmented reality holographic display to aid physician accuracy during cardiac ablation have been published in the Journal...

Caption Health gains FDA approval for updates to its cardiac AI...

Caption Health, a developer of medical artificial intelligence (AI) technology, has received US Food and Drug Administration (FDA) 510(k) clearance for an updated version...

Funding secured to further study of AI systems for cardiovascular health

Digital health and artificial intelligence (AI) company Eko has been awarded a US$2.7 million Small Business Innovation Research (SBIR) grant by the National Institutes...

Next-generation Watchman LAAC device gains US FDA approval

Boston Scientific has received US Food and Drug Administration (FDA) approval for the Watchman FLX left atrial appendage closure (LAAC) device. The device is...

LifeSignals receives US FDA clearance for the ECG Remote Monitoring Patch

LifeSignals Group has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for the LifeSignals ECG Remote Monitoring Patch platform. The...

Women taking beta blockers for hypertension may have higher risk of...

Women taking beta blockers for hypertension with no prior history of cardiovascular disease have a nearly 5% higher risk for heart failure than men...

AHA Scientific Sessions 2020 to be held virtually

The American Heart Association (AHA) has announced that its 2020 Scientific Sessions will be presented as a 100% virtual experience in light of the impact...

ACC publishes pathway on the management of bleeding in patients on...

The American College of Cardiology has published an expert consensus decision pathway (ECDP) on the management of bleeding in patients being treated with direct...

Continuous electrocardiogram monitoring post-stroke patients uncovers AF in 4.6% of patients

Screening patients in a primary care setting over one year after occurrence of a stroke using seven-day Holter monitoring uncovered atrial fibrillation (AF) in 4.6%...

Paper highlights use of robotic system for catheter ablation in COVID-19...

Stereotaxis has announced the publication of a paper in the European Heart Journal highlighting the benefits of using robotic technology for the management of...

Lower rate of post-ablation arrhythmia recurrence found in patients with shorter...

Patients with atrial fibrillation (AF) episodes limited to less than 24 continuous hours had a significantly lower incidence of arrhythmia recurrence following AF ablation...

Athena Poppas

Athena Poppas is chief of cardiology at the Alpert Medical School of Brown University (Providence, USA) and has recently begun her term as the...

AliveCor launches KardiaCare subscription service

AliveCor has announced the launch of KardiaCare, a digital health subscription service offering digital tools to monitor heart data, risk factors, identify symptom triggers,...

US and European approval for Medtronic’s LINQ II insertable cardiac monitor

Medtronic today announced that it has received US Food and Drug Administration (FDA) clearance and CE mark approval for its LINQ II insertable cardiac...

Abbott receives US FDA approval for Gallant ICD and CRT-D devices

Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronisation...

€3.7m funding round completed for cardiac AI developer inHEART

inHEART, developer of a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, has closed a funding round of €3.7m led...

Carag Bioresorbable Septal Occluder approved for US IDE trial

US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval has been granted for the Carag Bioresorbable Septal Occluder (CBSO). The CE-marked CBSO is...

Kardium receives CE mark for its Globe Mapping and Ablation System

Kardium has received CE mark approval for its Globe Mapping and Ablation System for the treatment of atrial fibrillation (AF). “This is an important milestone...

PCR e-Course 2020: Roll-in trial finds high device success rate for...

Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) device has a high implant success rate and a low procedural complication rate in...

PCR e-Course 2020: Left atrial appendage occlusion improves clinical outcomes versus...

Left atrial appendage occlusion (LAAO) improves clinical outcomes including ischaemic stroke, major bleeding and all-cause mortality, in atrial fibrillation (AF) patients with a high...

Tenfold risk of arrhythmias in intensive care COVID-19 patients

Patients with COVID-19 who were admitted to an intensive care unit were 10 times more likely than other hospitalised COVID-19 patients to suffer cardiac...

Philips receives FDA premarket approval for its HeartStart FR3 and HeartStart...

Royal Philips has announced that the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA) has granted premarket...

Smartphone app can identify lung congestion in heart failure patients

Voice analysis by a smartphone app can identify lung congestion in heart failure patients, allowing early intervention before their condition deteriorates, a study presented...

Medtronic’s Micra AV TPS receives CE mark

Medtronic has received CE mark for Micra AV Transcatheter Pacing System (TPS), the world’s smallest pacemaker with atrioventricular (AV) synchrony. Micra AV is indicated for...

First US patients treated using HeartLight X3 ablation system

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has announced that the first patients have been treated commercially with the recently-approved HeartLight X3 endoscopic ablation system in the USA. The cardiac...

Biotronik announces initial launch of its His-Bundle Pacing tools

Biotronik has announced its commitment to giving physicians additional tools to pace in the His-Bundle, coinciding with the launch of its His-Bundle Pacing (HBP)...

Occupation: Influencer

Jeffrey L Turner, Brian Zenger and Benjamin Steinberg (all University of Utah School of Medicine, Salt Lake City), write that social media has become...

Societies publish consensus statement on risk assessment in arrhythmias

Global cardiac health societies have collaborated on a consensus statement on the diagnosis of arrhythmias, designed to provide physicians with practical proposals to improve...

Optical mapping used to assess effect of hydroxychloroquine on heart rhythm

Researchers have used an optical mapping system to observe how the malaria drug hydroxychloroquine, which has been touted as a possible treatment for COVID-19,...

Adagio Medical receives CE mark for iCLAS ablation system

Adagio Medical has received CE mark approval for its ultra-low temperature intelligent Continuous Lesion Ablation System (iCLAS) for the endocardial treatment of paroxysmal (PAF)...

Cardiologists plot “return to normal” as COVID-19 restrictions ease

As electrophysiologists worldwide begin the process of restarting elective procedures put on hold due to the COVID-19 pandemic, cardiology departments are braced for a...

Cardiac Rhythm News Issue 48 – May 2020

Highlights: Cardiologists discuss the "return to normal" as COVID-19 restrictions ease Late breaking trials from HRS 2020 Science including: PRAETORIAN, UNTOUCHED and PINNACLE FLX ...

Bardy Diagnostics receives CE mark for 14-day CAM patch

Bardy Diagnostics has received CE mark certification for the 14-day version of the Carnation Ambulatory Monitor (CAM) patch, the p-wave centric ambulatory cardiac patch...

Heart Rhythm Congress moves to virtual event for 2020

The 2020 edition of the Heart Rhythm Congress (HRC 2020), which had been scheduled to take place 27–30 September in Birmingham, UK, has been...

Lancet study finds no benefit in use of hydroxychloroquine for COVID-19

A study into the use of hydroxychloroquine or chloroquine, published in The Lancet, has failed to find a benefit in hospital-outcomes from the use...

Music triggers individualised cardiac response

Play the same piece of music to two people, and their hearts can respond very differently. That is the conclusion of a study presented...

Eko launches AI-powered telehealth platform for cardiac exams

Eko has announced the launch of Eko Telehealth, an artificial intelligence (AI)-powered telehealth platform for virtual cardiac and pulmonary monitoring. Being used by more...

Acutus Medical and Biotronik announce electrophysiology alliance

Acutus Medical and Biotronik have announced a new alliance to provide a comprehensive portfolio of electrophysiology, mapping, ablation and accessory products for catheter-based treatment...

AI-based ECG analysis reduces false positives in AF detection

Cardiologs, in partnership with the Valley Health System, has announced the results of a clinical study that found the Cardiologs AI-based ECG analysis solution...

Durablate catheter results demonstrate feasibility in VT ablation

Thermedical has announced that results from a first-in-human early feasibility study (EFS) using the Durablate catheter to treat ventricular tachycardia (VT) were presented in...

Philips gains FDA clearance for the use of its ultrasound portfolio...

Royal Philips has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market a wide range of...

The evolution of cardiac care in the wake of COVID-19

David E Albert, founder and chief medical officer of AliveCor, considers the impact of the COVID-19 pandemic on the  monitoring and of management of...

FDA approves update to cardiac imaging system to aid COVID-19 diagnostics

The US Food and Drug Administration (FDA) has expedited clearance of an update to software from Caption Health, a medical artificial intelligence (AI) company,...

US FDA approval granted for HeartLight X3 endoscopic ablation system

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has announced that the US Food and Drug Administration (FDA) has approved the next-generation HeartLight X3 endoscopic ablation system for the treatment of...

Medtronic receives US FDA approval for Cobalt and Crome implantable ICDs

Medtronic has received US Food and Drug Administration (FDA) approval for its Cobalt and Crome implantable cardioverter-defibrillators (ICD) and cardiac resynchronisation therapy-defibrillators (CRT-D). ICDs monitor...

CONVERGE IDE trial results presented at HRS 2020 Science

AtriCure has announced results from the CONVERGE IDE clinical trial, which showed an 18% difference in favour of the hybrid Convergent procedure as compared...

HRS 2020 Science: UNTOUCHED study finds improved inappropriate shock rate using...

Findings from the UNTOUCHED study, presented online in a late-breaking trial session at HRS 2020 Science, showed that patients receiving subcutaneous implantable cardioverter defibrillator...

Medtronic shares results of BlueSync and Micra TPS CED studies

Medtronic has announced results from late breaking clinical trials, presented online at HRS 2020 Science, evaluating the MyCareLink Heart mobile app and the Micra...

Contact force sensing catheters “safe and effective” in persistent AF ablation

Contact force (CF) sensing catheters have been shown to be safe and effective in persistent atrial fibrillation (AF) ablation, according to the findings of...

Boston Scientific announces positive PINNACLE FLX study results

Boston Scientific has announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX Left...

HRS 2020 Science: PRAETORIAN trial demonstrates non-inferiority of S-ICDS compared to...

Subcutaneous implantable cardioverter defibrillators (S-ICDs) are as protective as transvenous implantable cardioverter-defibrillators (ICDs) in the prevention of sudden cardiac death, but have a better...

Results of PULSED AF trial presented at HRS 2020 Science

Initial results of the PULSED AF trial, the first-in-human results for paroxysmal or persistent atrial fibrillation (AF) treated with pulsed field ablation (PFA) were...

Heart Rhythm Society launches white paper on AF centres of excellence

New ESC guidelines on SVTs
The Heart Rhythm Society (HRS) has released a white paper announcing the rationale and core components for Atrial Fibrillation (AF) centres of excellence (CoE),...

Fitbit to enrol patients in AF detection study

Fitbit has today launched the Fitbit Heart Study, its first large-scale, virtual study to validate the use of its wearable technology to identify episodes...

LifeSignals receives CE mark for the ECG Remote Monitoring Patch

LifeSignals has received CE mark approval for the LifeSignals ECG Remote Monitoring Patch, a disposable wireless remote monitoring system, intended for use by healthcare...

Sex and race disparities found in ICD interventions for cardiac patients

Results of a clinical trial show stark disparities in the use of life-saving implantable cardioverter defibrillator (ICD) interventions based on sex and race, suggesting...

VitalConnect granted Emergency Use Authorisation for cardiac monitoring in COVID-19 patients

VitalConnect has been granted Emergency Use Authorisation (EUA) status by the US Food and Drug Administration (FDA) as part of the response to the...

Study points to potential treatment for long QT syndrome

A study published in the Journal of the American College of Cardiology (JACC) provides the first direct evidence that KCNQ1 antibodies are able to...

Same-day discharge “feasible for majority of AF ablation patients”

Same-day discharge after atrial fibrillation (AF) ablation is feasible for the majority of patients when a standardised protocol is used, findings of a multicentre cohort study, published in the Journal of the American...

iRhythm offers home enrolment of Zio monitoring devices

iRhythm Technologies collaboration
iRhythm Technologies has announced a virtual platform to support patients and clinicians in the wake of COVID-19 by offering home enrolment for the company’s...

Coala Heart Monitor expands capabilities for monitoring COVID-19 patients

Coala Life has announced the expansion of capabilities to help monitor patients from home using the Coala Heart Monitor. This expansion is a result...

iRhythm makes board appointment

iRhythm Technologies has announced the appointment of Renee Budig to its Board of Directors effective 23 April 2020. Budig was appointed as a Class...

FDA advises close screening of COVID-19 patients receiving hydroxychloroquine

The US Food and Drug Administration (FDA) has issued a Drug Safety Communication regarding known side effects of hydroxychloroquine and chloroquine, including serious and...

Mobile telemetry can aid QTc monitoring of COVID-19 patients

The use of mobile cardiac outpatient telemetry (MCOT) can help monitor COVID-19 patients taking hydroxychloroquine and azithromycin, while reducing potential exposure to the virus...

Heart Rhythm Society provides further advice for using hydroxychloroquine to treat...

The Heart Rhythm Society (HRS) COVID-19 Rapid Response Task Force has updated its guidance on QTc monitoring in COVID-19 patients. In the revised guidance,...

EU-funded project to assess AF screening algorithm

The European Society of Cardiology (ESC) is participating in two large-scale EU-funded projects to detect heart rhythm disorders and prevent sudden cardiac death. The first...

AI study launched to monitor cardiac safety of COVID-19 patients receiving...

  Cardiologs has announced the launch of a clinical study using the company’s artificial intelligence (AI) solution to remotely monitor the cardiac safety of COVID-19...

Cardiac Insight launches Heart@Home ECG test kit

Cardiac Insight has announced the launch of the Heart@Home electrocardiogram (ECG) test kit to address new telehealth demands placed on cardiology practices by the...

Vivek Reddy joins DiNovA Medtech as chief medical advisor

DiNovA Medtech has announced that Vivek Reddy will join the company as chief medical advisor and co-founder of portfolio company Nuomao Medtech to lead...

Carnation Ambulatory Monitor patch used to detect arrhythmias in COVID-19 patients

Bardy Diagnostics has announced that its Carnation Ambulatory Monitor (CAM) Patch has been chosen for use in protocols to measure QT Segments in COVID-19...

US heart societies express concern over using hydroxychloroquine and azithromycin for...

Presidents of leading cardiac organisations, including the American Heart Association (AHA), the American College of Cardiology (ACC) and the Heart Rhythm Society (HRS), have...

Webinar: Cardiovascular specialists detail COVID-19 strategies

Cardiovascular specialists from across the globe shared current knowledge and key experience of managing COVID-19 patients as part of a webinar organised by the...

AHA issues oxygenation and ventilation guidance for healthcare providers

The American Heart Association (AHA), in conjunction with the American Association for Respiratory Care (AARC) and American Society of Anesthesiologists (ASA) is offering guidance...

Heart Failure 2020 in Barcelona cancelled

The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has announced that Heart Failure 2020 & the World Congress on Acute...

Athena Poppas begins ACC presidency

Athena Poppas (Providence, USA) is the new president of the American College of Cardiology (ACC). Her term officially began at the close of the...

HRS 2020 in San Diego cancelled due to COVID-19 concerns

Cardiac Rhythm news for specialists
Due to COVID-19 concerns and travel restrictions, the 2020 Heart Rhythm Scientific Sessions (HRS 2020) will not take place in San Diego, USA, on...

Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy

Results from the phase 2 MAVERICK-HCM clinical trial, presented at the American College of Cardiology/World Congress of Cardiology’s virtual scientific sessions (ACC.20/WCC Virtual) suggest that...

Virtual ACC: LivaNova highlights Vitaria data

Data on the use of LivaNova’s implantable neuromodulation technology, Vitaria, for heart failure patients has been shared at the American College of Cardiology/World Congress...

Virtual ACC: Ethanol infusion in vein of Marshall improves catheter ablation outcomes 

The infusion of ethanol via the vein of Marshall (VOM), coupled with catheter ablation, leads to improved outcomes for patients with persistent atrial ablation, according to the findings of a study presented by...

AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research

The American Heart Association (AHA) has committed US$2.5 million to research efforts to better understand the novel coronavirus, COVID-19, and its interaction with the...

Funding round for developer of wrist-mounted blood pressure monitor

Aktiia, a Swiss-US start-up that has developed an optical blood pressure monitor at the wrist, has raised an additional CHF 6 million in funding...

Study recommends “widespread adoption” of CVC for CIED implantation

Cephalic vein cutdown (CVC) and axillary vein access (AVA) are both effective approaches for cardiac implantable electronic device (CIED) lead implantation, and could avoid...

Stereotaxis receives FDA clearance for Genesis Robotic Magnetic Navigation system

Stereotaxis has received US Food and Drug Administration (FDA) 510(k) clearance for the Genesis Robotic Magnetic Navigation (RMN) system for the robotic navigation of...

Focus on the Zio Patch wearable sensor in diagnosis of cardiac...

James Teo was the chief investigator in the EPACS clinical trial, testing the performance of the Zio Patch (iRhythm Technologies) wearable biosensor. He outlines...

EHRA 2020 to feature late-breaking arrhythmia studies

Twenty late-breaking trials, including major clinical studies on the treatment of atrial fibrillation (AF) are among the research to be presented at the annual...

Kalyanam Shivkumar named as editor-in-chief of JACC: Clinical Electrophysiology

Kalyanam Shivkumar has been named the next editor-in-chief of the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology. Shivkumar is a physician scientist...

Wearable sensor analytics platform predicts worsening heart failure prior to hospitalisation

Wearing an adhesive patch sensor that streams data to an analytical platform can accurately predict worsening heart failure (HF) and the need for hospitalisation...

Append Medical shares clinical proof-of-concept results for internal sealing of LAA

Append Medical, developer of the Appligator, a novel left atrial appendage (LAA) closure device to minimise stroke risk in atrial fibrillation (AF) patients, and...

Abbott receives CE mark approval for Gallant ICD and CRT-D devices

Abbott has announced that it has received CE mark approval for the Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy defibrillator (CRT-D) devices. The...

One in three patients treated in line with ICD guidelines

Decline in defibrillation testing during ICD implantation
A study of patients undergoing implantable cardioverter defibrillator (ICD) therapy across three centres, found that only one in three were treated in concordance with...

VitalConnect adds arrhythmia detection to its remote monitoring software

VitalConnect has announced the introduction of arrhythmia detection to its remote monitoring portfolio. In partnership with CorVitals, VitalConnect now offers physicians the ability to...

ACC partners with AED device company for cardiac arrest alliance

The American College of Cardiology (ACC) and automated external defibrillator (AED) technology start-up HeartHero have formed an alliance aimed at making a “significant impact”...

AI-guided cardiac imaging system given FDA authorisation

The US Food and Drug Administration (FDA) has authorised marketing of software to assist in the acquisition of cardiac ultrasound, or echocardiography, images. The...

CardioFocus submits HeartLight X3 PMA application to FDA

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has submitted a pre-market approval (PMA) supplement to the US Food and Drug Administration (FDA) for the HeartLight X3 Endoscopic Ablation System for...

Value of augmented reality goes well beyond holograms in the electrophysiology...

 Jennifer Silva (St Louis, USA) talks to BLearning Cardio at SIR 2019 (Society of Interventional Radiology; 23–28 March; Austin, USA) about why physicians should...

Medtronic receives CE Mark for Cobalt and Crome implantable ICDs

Medtronic has received CE Mark for its Cobalt and Crome portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy-defibrillators (CRT-D). ICDs monitor heart rhythms...

Eko receives FDA clearance for AF and heart murmur algorithms

Eko has announced that the US Food and Drug Administration (FDA) has cleared a suite of algorithms that, when combined with Eko’s digital stethoscopes,...

AF Symposium 2020: Acutus Medical live streams case using AcQMap System

Acutus Medical offered a demonstration of its AcQMap advanced cardiac imaging and mapping system at AF Symposium (23–25 January, Washington, DC, USA) with a live-stream...

Medtronic gains FDA approval for PulseSelect trial

Medtronic has received approval from the US Food and Drug Administration (FDA) to proceed with an investigational device exemption (IDE) trial to evaluate the...

BardyDx announces commercial launch of the 14-day CAM Patch

Bardy Diagnostics (BardyDx) has today announced the commercial launch of the 14-Day version of the Carnation Ambulatory Monitor (CAM), the P-wave centric ambulatory cardiac...

Biotronik announces Japanese launch of injectable cardiac monitor

biomonitor
Biotronik has announced the market release of its injectable cardiac monitor (ICM), BioMonitor III in Japan. The device is designed to help patients with...

Hypocapnia could aid ablation of cardiac arrhythmias

A technique that enables patients suffering from heart conditions to hold their breath safely for over five minutes could have potential as a treatment...

AI and its growing role in arrhythmia

Malcom Finlay (Bart's Health Centre, London, UK) reviews the growing role of artificial intelligence (AI) in diagnosing arrhythmias.  Johnny, a 72-year-old film producer, is meeting...

Medtronic receives FDA approval for Micra AV

Medtronic has announced that it has received US Food and Drug Administration (FDA) approval of Micra AV, the world’s smallest pacemaker with atrioventricular (AV)...

CardioFocus appoints Burke T Barrett as chief executive

CardioFocus, has announced that the company’s board of directors has promoted Burke T Barrett to the position of chief executive officer (CEO), effective January...

First patient enrolled in PREDICT-LAA clinical trial

FEops has announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA trial. The trial is led by Righshospitalet (Copenhagen, Denmark) and aims...

Cardiac Rhythm News Issue 47 – January 2020

Cardiac Rhythm News Issue 47
Highlights: WRAP-IT shows significant mortality risk with CIED infection, and reduced quality of life Sequential approach using STAR mapping system identifies key early sites...

Leading electrophysiologists identify four key studies that will shape arrhythmia treatment...

Leading electrophysiologists have pinpointed four clinical studies due to report findings in 2020—AMULET IDE, aMAZE IDE, PULSED AF and CEASE AF—that they expect to...

Persistent atrial fibrillation—seeking the sources of the cardiac electrical field

Andrew Grace charts the evolution of non-contact mapping culminating in the current AcQMap system—the technology has advanced understanding of persistent atrial fibrillation (AF), providing...

Eric N Prystowsky

Eric Prystowsky
Eric N Prystowsky (director of the Cardiac Arrhythmia Service at St Vincent Hospital, Indianapolis, and a consulting professor of medicine at Duke University Medical...

NICE recommends use of Reveal LINQ implantable cardiac monitor

The UK National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending the use of the Reveal LINQ (Medtronic) implantable cardiac...

Ed Vertatschitsch joins Bardy Diagnostics as chief operating officer

Bardy Diagnostics (BardyDx) has announced today the appointment of Ed Vertatschitsch as chief operating officer. Effective 2 January 2020, the appointment will see Vertatschitsch...

ACC makes senior staff appointments

American College of Cardiology makes senior staff appointments
The American College of Cardiology (ACC) has announced several promotions and structural changes within its senior staff. The College said that the staff changes...

Stryker launches voluntary field action for LIFEPAK 15

Stryker
Stryker has launched a voluntary field action on specific units of the LIFEPAK 15 monitor and defibrillator. In an announcement issued by the company on...

AtriCure announces completion of enrolment for aMAZE clinical trial

  AtriCure has announced the successful completion of patient enrolment in the aMAZE clinical trial. In addition, the company announced that it has received approval...

FDA grants Breakthrough designation for ECG-based algorithm

ECG based algorithm
The US Food and Drug Administration has granted Breakthrough Device designation to the digital health and artificial intelligence (AI) company Eko for an echocardiogram...

European trial data ‘reinforce’ safety profile and efficacy of Lixiana

European Trial Data
Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial fibrillation (AF) patients being treated with the anti-coagulation drug edoxaban...

First patients treated in robotic arrhythmia care programme at Overland Park...

Dhanunjaya Lakkireddy performs the first robotic cardiac ablation procedure at OPRMC
Stereotaxis announced today that HCA Midwest Health has launched a new robotic arrhythmia care programme based at Overland Park Regional Medical Center (OPRMC). Installation...

FDA panel votes against approval of AF drug Brinavess

Cardiac Rhythm news for specialists
The US Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) has voted not to recommend approval for the anti-arrhythmic drug...

Impulse Dynamics secures funding to commercialise Optimizer Smart

Impulse Dynamics has announced the completion of a US$80.25 million Series D financing round with new investors. Proceeds will be used primarily to facilitate...

Tackling focal VT may improve catheter ablation in structural heart disease

Uncovering and abolishing focal ventricular tachycardia (VT) may further improve outcomes of catheter ablation in the treatment of structural heart disease, a study published...

VivaLnk’s multi-vital wearable sensor and software development kit receive CE mark

VivaLnk has announced it has received the class IIa medical device CE mark for its multi-vital medical wearable sensor and software development kit (SDK). The...

PADIT score predicts CIED infection risk

Five independent predictors of cardiac implantable electronic device (CIED) infection have been identified which could be used to aid physicians and patients in decision-making...

Pedro Brugada

With his brothers Josep and Ramon, Pedro Brugada discovered the syndrome that bears their name. He reflects on his career highlights with Cardiac Rhythm...

AHA 2019: Correvio announces new data from SPECTRUM Brinavess study

Cardiac Rhythm news for specialists
Correvio announced the presentation of new data from the SPECTRUM study evaluating Brinavess (vernakalant hydrochloride, IV), an antiarrhythmic drug for the rapid conversion of...

Cardiac Rhythm News Issue 46 – October 2019

Highlights: ESC guidelines on supraventricular tachycardias underline the pivotal role of catheter ablation therapy Study suggests increased use of DOACs in AF leads to...

Left atrial appendage closure associated with a decreased stroke risk in...

Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk of admission for stroke, compared with the expected risk without...

First patients treated using integrated navigation technology from Stereotaxis and ADAS...

Stereotaxis and ADAS 3D Medical have announced that the first patients have been treated with the integration of ADAS 3D’s advanced preoperative substrate mapping...

CardioFocus treats first patients with HeartLight endoscopic ablation system in France

The HeartLight Excalibur Balloon used with the HeartLight X3 system
CardioFocus has announced that the first patients in France have been treated in the University Public Hospital of Nancy with the HeartLight endoscopic ablation...

Cardiva Medical announces publication of data from AMBULATE pivotal study

Cardiva Medical has said that results from the AMBULATE pivotal study demonstrate the safety and efficacy of its VASCADE MVP venous vascular closure system...

Bardy Diagnostics wins digital health pitch session at ESC Congress

Bardy Diagnostics announced that it was selected as winner of the ‘Remote Monitoring in Arrhythmias’ Technology and Innovation Pitch Session held as part of...

Low bleeding and cardiovascular events in elderly NVAF patients using edoxaban,...

Cardiac Rhythm news for specialists
Daiichi Sankyo has announced one-year follow-up results from an analysis of 12,574 European non-valvular atrial fibrillation (NVAF) patients, mostly elderly, treated with edoxaban (Lixiana)....